NCT01607918Unknown4 期
Comparison of the Efficacy of Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy for 10 Days in the First Line Therapy for Helicobacter Pylori Infection- A Multicenter Randomized Comparative Trial
适应症
相关药物
试验速览
- 阶段
- 4 期
- 入组人数
- 1,300
- 试验地点
- 2
- 主要终点
- Eradication rate according to Intention to treat (ITT) and per-protocol (PP) analysis
研究概览
简要总结
The investigators aimed to compare the eradication rates of sequential therapy for 10 days versus triple therapy for 14 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients are aged greater than 20 years who have H. pylori infection without prior eradication therapy and are willing to receive the sequential therapy will be eligible for enrollment.
- •Written informed consents will be obtained from all patients prior to enrollment.
排除标准
- •Patients will be excluded from the study if any one of the following criteria is present:
- •children and teenagers aged less than 20 years,
- •history of gastrectomy,
- •gastric malignancy, including adenocarcinoma and lymphoma,
- •previous allergic reaction to antibiotics (amoxicillin, clarithromycin, levofloxacin, metronidazole) and prompt pump inhibitors (lansoprazole), - contraindication to treatment drugs,
- •pregnant or lactating women,
- •severe concurrent disease
- •Patients who cannot give informed consent by himself or herself.
结局指标
主要结局
Eradication rate according to Intention to treat (ITT) and per-protocol (PP) analysis
时间窗: 6 weeks
C13-UBT will be used to assess the existence of H. pylori
次要结局
- Incidence of adverse effects(during eradication therapy)
研究者
National Taiwan University Hospital
Doctor and Principle Investigator, Department of Gastroenterology
National Taiwan University Hospital
研究点 (2)
Loading locations...
相似试验
Unknown
4 期
Sequential Therapy Versus Quadruple Therapy in H. Pylori EradicationHelicobacterNCT03156855National Taiwan University Hospital620
已完成
不适用
Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori EradicationHelicobacter Pylori InfectionNCT01306786The University of Hong Kong800
撤回
4 期
Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.PyloriHelicobacter Pylori Gastrointestinal Tract InfectionNCT03021590Damascus Hospital
Unknown
4 期
Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. PyloriHelicobacter Pylori Gastrointestinal Tract InfectionNCT02693574Damascus Hospital74
已完成
3 期
Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic BronchitisAcute Bacterial Exacerbation of Chronic Bronchitis (ABECB).NCT00645086Abbott465
